Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 12, 2016 - Issue 3
Submit an article Journal homepage
2,034
Views
26
CrossRef citations to date
0
Altmetric
Reviews

Pancreatic cancer: Update on immunotherapies and algenpantucel-L

Kinsey A. McCormickUniversity of Washington, Seattle, WA, USA
,
Andrew L. CovelerUniversity of Washington, Seattle, WA, USA
,
Gabriela R. RossiNewLink Genetics, Ames, IA, USA
,
Nicholas N. VahanianNewLink Genetics, Ames, IA, USA
,
Charles LinkNewLink Genetics, Ames, IA, USA
&
E. Gabriela ChioreanUniversity of Washington, Seattle, WA, USACorrespondence[email protected]
Pages 563-575 | Received 08 Jun 2015, Accepted 07 Sep 2015, Published online: 05 May 2016

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Maximos Frountzas, Konstantinos Apostolou & Dimitrios Schizas. (2022) Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights. Cancer Management and Research 14, pages 1043-1061.
Read now
Gustavo C. L. Gössling, David B. Zhen, Venu G. Pillarisetty & E. Gabriela Chiorean. (2022) Combination immunotherapy for pancreatic cancer: challenges and future considerations. Expert Review of Clinical Immunology 18:11, pages 1173-1186.
Read now

Articles from other publishers (24)

Tarak Chouari, Francesca Soraya La Costa, Nabeel Merali, Maria-Danae Jessel, Shivan Sivakumar, Nicola Annels & Adam E. Frampton. (2023) Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma. Cancers 15:17, pages 4265.
Crossref
Mohammad Chehelgerdi & Matin Chehelgerdi. (2023) The use of RNA-based treatments in the field of cancer immunotherapy. Molecular Cancer 22:1.
Crossref
Liang Yu, Risheng He & Yunfu Cui. (2023) Characterization of tumor microenvironment and programmed death-related genes to identify molecular subtypes and drug resistance in pancreatic cancer. Frontiers in Pharmacology 14.
Crossref
Pooya Farhangnia, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi & Ali-Akbar Delbandi. 2023.
Tinkara Remic, Gregor Sersa, Kristina Levpuscek, Ursa Lampreht Tratar, Katja Ursic Valentinuzzi, Andrej Cör & Urska Kamensek. (2022) Tumor cell-based vaccine contributes to local tumor irradiation by eliciting a tumor model-dependent systemic immune response. Frontiers in Immunology 13.
Crossref
Daniel C. Osei-Bordom, Nikolaos Serifis, Zachary J. Brown, D. Brock Hewitt, Gbemisola Lawal, Gagandeep Sachdeva, Daniel J. Cloonan & Timothy M. Pawlik. (2022) Pancreatic ductal adenocarcinoma: Emerging therapeutic strategies. Surgical Oncology 43, pages 101803.
Crossref
Caitlyn Smith, Wei Zheng, Jixin Dong, Yaohong Wang, Jinping Lai, Xiuli Liu & Feng Yin. (2022) Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy. World Journal of Gastroenterology 28:27, pages 3297-3313.
Crossref
Ilene Le, Subramanian Dhandayuthapani, Jessica Chacon, Anna M. Eiring & Shrikanth S. Gadad. (2022) Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics. Vaccines 10:5, pages 816.
Crossref
荔文 郑. (2022) Research Progress in Immunotherapy of Pancreatic Cancer. Advances in Clinical Medicine 12:02, pages 1169-1177.
Crossref
Daniel Brock Hewitt, Nicholas Nissen, Hassan Hatoum, Benjamin Musher, John Seng, Andrew L. Coveler, Raed Al-Rajabi, Charles J. Yeo, Benjamin Leiby, Joshua Banks, Lodovico Balducci, Gina Vaccaro, Noelle LoConte, Thomas J. George, Warren Brenner, Emad Elquza, Nicholas Vahanian, Gabriela Rossi, Eugene Kennedy, Charles Link & Harish Lavu. (2022) A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer. Annals of Surgery 275:1, pages 45-53.
Crossref
Jianfeng Ding, Xiaobo He, Xiao Cheng, Guodong Cao, Bo Chen, Sihan Chen & Maoming Xiong. (2021) A 4-gene-based hypoxia signature is associated with tumor immune microenvironment and predicts the prognosis of pancreatic cancer patients. World Journal of Surgical Oncology 19:1.
Crossref
Lorena Ostios-Garcia, Julia Villamayor, Esther Garcia-Lorenzo, David Vinal & Jaime Feliu. (2021) Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer. World Journal of Gastroenterology 27:40, pages 6775-6793.
Crossref
Motoki Miyazawa, Masahiro Katsuda, Manabu Kawai, Seiko Hirono, Ken‐ichi Okada, Yuji Kitahata & Hiroki Yamaue. (2021) Advances in immunotherapy for pancreatic ductal adenocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 28:5, pages 419-430.
Crossref
Chi-Ping Huang, Chi-Yu Yang & Chih-Rong Shyr. (2021) Utilizing Xenogeneic Cells As a Therapeutic Agent for Treating Diseases. Cell Transplantation 30, pages 096368972110119.
Crossref
Valerie Jentzsch, James Davis & Mustafa Djamgoz. (2020) Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management. Cancers 12:11, pages 3096.
Crossref
Dimitrios Schizas, Nikolaos Charalampakis, Christo Kole, Panagiota Economopoulou, Evangelos Koustas, Efthymios Gkotsis, Dimitrios Ziogas, Amanda Psyrri & Michalis V. Karamouzis. (2020) Immunotherapy for pancreatic cancer: A 2020 update. Cancer Treatment Reviews 86, pages 102016.
Crossref
Bonala Sabeerabi, Venkat R. Arva Tatireddygari & Ramakrishna Vadde. 2020. Immunotherapy for Gastrointestinal Malignancies. Immunotherapy for Gastrointestinal Malignancies 113 158 .
S. K. Daniel, K. M. Sullivan, K. P. Labadie & V. G. Pillarisetty. (2019) Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma. Clinical and Translational Medicine 8:1.
Crossref
Brankica Filipić & Zorica Stojić-Vukanić. (2019) Active immunotherapy of cancer: An overview of therapeutic vaccines. Arhiv za farmaciju 69:6, pages 490-506.
Crossref
Markus Kieler, Matthias Unseld, Daniela Bianconi & Gerald Prager. (2018) Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas. Pancreas 47:2, pages 142-157.
Crossref
Nils Elander, Karen Aughton & William Greenhalf. 2018. Pancreatic Cancer. Pancreatic Cancer 1273 1304 .
Jianqin Lu, Xiangsheng Liu, Yu-Pei Liao, Felix Salazar, Bingbing Sun, Wen Jiang, Chong Hyun Chang, Jinhong Jiang, Xiang Wang, Anna M. Wu, Huan Meng & Andre E. Nel. (2017) Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression. Nature Communications 8:1.
Crossref
Erik S. Knudsen, Paris Vail, Uthra Balaji, Hoai Ngo, Ihab W. Botros, Vladimir Makarov, Nadeem Riaz, Vinod Balachandran, Steven Leach, Debrah M. Thompson, Timothy A. Chan & Agnieszka K. Witkiewicz. (2017) Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers. Clinical Cancer Research 23:15, pages 4429-4440.
Crossref
Nils Elander, Karen Aughton & William Greenhalf. 2017. Pancreatic Cancer. Pancreatic Cancer 1 32 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.